Glusyn 600 Injection contains 600 mg of Glutathione, a potent antioxidant naturally present in the body, essential for cellular protection against oxidative stress and free radical damage. This injectable formulation is primarily indicated for the management of conditions associated with oxidative damage, including liver disorders such as chronic hepatitis, alcoholic liver disease, and non-alcoholic fatty liver disease. Glutathione plays a crucial role in detoxification processes by conjugating with harmful substances, facilitating their elimination from the body. Additionally, Glusyn 600 Injection is utilized as an adjunct therapy in certain neurodegenerative diseases and to improve skin complexion by reducing melanin synthesis through its depigmenting effects. The administration of Glusyn 600 is typically performed intravenously or intramuscularly under medical supervision, ensuring optimal bioavailability and rapid onset of action. Dosage and duration of treatment should be individualized based on the patient’s clinical condition and response to therapy. Adverse effects are generally rare but may include mild injection site reactions or allergic responses. Glusyn 600 Injection should be used cautiously in patients with known hypersensitivity to glutathione or any component of the formulation. Proper medical evaluation and monitoring are recommended to maximize therapeutic benefits while minimizing potential risks.